Clinical Trials Directory

Trials / Completed

CompletedNCT06523686

Lateral Ridge Augmentation Using Two Graft Combination and a Cross-linked Collagen Membrane

Lateral Ridge Augmentation Using Autogenous-xenogeneic or Allogeneic-xenogeneic Graft Mix With a Cross-linked Collagen Membrane: a Randomized Pilot Clinical Trial

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Saint-Joseph University · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

To treat resorbed alveolar ridges, many surgical procedures are available in the literature such as ridge splitting, distraction osteogenesis, block grafting techniques and guided bone regeneration, which is the most documented technique. Various grafting materials are available but there is a lack of evidence on the superiority of a material or a combination of materials.

Detailed description

Bone width at the implant site is an important prerequisite for a predictable and long-term prognosis in implant dentistry. Different types of membranes and bone grafts are used in the GBR procedure. However, there is a lack of studies in the literature about the combination allograft/xenograft. The aim of the present trial is to compare two different bone graft combinations (autogenous-xenogeneic and allogeneic-xenogeneic) covered with a cross-linked collagen membrane in a horizontal alveolar ridge augmentation (without simultaneous implant placement).

Conditions

Interventions

TypeNameDescription
PROCEDUREGuided bone regenerationCompare the linear and volumetric bone width changes, clinically and radiographically, between two different bone graft combinations (autogenous-xenogeneic and allogeneic-xenogeneic) covered with a cross-linked collagen membrane in a horizontal GBR.

Timeline

Start date
2023-01-09
Primary completion
2024-06-10
Completion
2024-07-10
First posted
2024-07-26
Last updated
2024-07-26

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT06523686. Inclusion in this directory is not an endorsement.